allergic rhinitis symptoms
Conditions
Interventions
Experimental group:Traditional acupuncture on bilateral LI20 (Yingxiang), GB20 (Fengchi), LI4 (Hegu), ST36 (Zusanli) and EX-HN3 (Yintang). Herbal moxibustion, Tianjiu No.1 will be pasted on the follow
(to be continued):A total of 12 acupuncture treatment sessions (3 times a week) and/or four sessions of herbal moxibustion treatment (once a week), respectively. acupuncture treatment sessions (3/week
herbal moxibustion treatment (1/week) for 1 month.
Sponsors
Department of Chinese Medicine, Hospital Authority
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Medical history: the subject has a history of allergic rhinitis, which is related to change in temperature and allergens such as pollen, dust mites, etc; 2. Clinical symptoms: the subject has the primary symptoms of nasal congestion, runny nose, sneezing and nasal itchiness. Subjects must have two or more of these symptoms; 3. Aged between 18 - 65; 4. A Total Nasal Symptom Score (TNSS) = 4; 5. The subject agrees to take part in this study and is fully capacitated, can express personal will and accurately describe symptoms.
Exclusion criteria
Exclusion criteria: 1. Has undertaken Chinese medicine treatment related to allergic rhinitis over the past month; 2. Has contracted respiratory infection or acute paranasal sinusitis within the past 14 days; 3. Has a history of chronic paranasal sinusitis; 4. Has organic nasal pathological changes or has had nasal surgeries; 5. Has asthma and other respiratory attack conditions; 6. Has taken antihistamines, steroids, decongestants (used on the nose, the mouth and the eyes), antibiotics, anti-coagulant and anti-platelet agents in the past month; 7. Has undertaken specific immune treatment or systemic hormone therapy in the past year; 8. Has serious cardiac, liver, renal, cerebrovascular conditions, or neural or mental disorders, etc.; 9. Be pregnant or nursing, or planning to conceive during the course of treatment; 10. Has G6PD; 11. Has wounds at the punctured locations or diabetes mellitus.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TNSS; | — |
Secondary
| Measure | Time frame |
|---|---|
| RQLQ;Total IgE; | — |
Countries
China
Contacts
Public ContactZHANG Hongwei
School of Chinese Medicine
Outcome results
None listed